NASDAQ IMMY

Below are some of the most frequently asked questions about Imprimis stock.  If you don't find what you're looking for here, please contact us directly.

1. Where are Imprimis’ shares traded?

Imprimis is traded on the Nasdaq Capital Markets

2. What is Imprimis’ ticker symbol?

Imprimis trades under the symbol IMMY

3. Who is Imprimis’ transfer agent?

Action Stock Transfer Corporation

4. What is a transfer agent?

A trust company, bank or similar financial institution assigned by a corporation to maintain records of investors and account balances and transactions, to cancel and issue certificates, to process investor mailings and to deal with any associated problems (i.e. lost or stolen certificates).

5. Does Imprimis pay dividends?

We have never paid dividends on our common stock and we do not expect to do so in the foreseeable future.

6. How do I receive electronic delivery of annual reports?

You can download a copy of our annual report here.

7. When is Imprimis’ fiscal year end?

Imprimis’ fiscal year end is December 31.

8. Who are Imprimis’ independent public accountants?

KMJ Corbin & Company, LLP

9. I am a stockholder of record of Imprimis common stock. How do I report a change of mailing address?

Requests for address changes may be made by telephone or letter to Action Stock Transfer Corporation. Action Stock Transfer Corporation may be reached in several ways.

Action Stock Transfer Corporation
2469 E. Fort Union Blvd., Suite 214
Salt Lake City, UT 84121
Phone: 801.274.1088
URL: www.actionstocktransfer.com

10. How do I replace my lost (stolen) stock certificates?

Our transfer agent, Action Stock Transfer Corporation, will perform any necessary replacements. A fee is associated with this service.

In regards to a lost or stolen certificate please contact Action Stock Transfer Corporation by phone using the following number:
801.274.1088

Stay Connected

Imprimis Pharmaceuticals, Inc.
Investor Relations
12264 El Camino Real, Suite 350
San Diego, CA 92130
T: 858.704.4040 | F: 858.345.1745

Contact Us Today

 

Stay Informed

Interested in receiving investor news and updates?

Click Here


Download Imprimis’ IR App for smart phones and tablets for the latest news, reports, presentations and more.